سهم تغيير تاريخ
Acadia Pharmaceuticals USD 40.36M 68.31M 2026-09
Alnylam Pharmaceuticals USD 105.91M 8.8M 2026-09
Amgen USD 6.39B 169M 2026-09
BioCryst Pharmaceuticals USD 13.74M 7.68M 2026-09
Biogen USD 2.22B 159.9M 2026-09
BioMarin Pharmaceutical USD 1.8B 13.54M 2026-09
Cytokinetics USD 807K 427K 2026-09
Daiichi Sankyo JPY 733.05B 40.68B 2026-06
Gilead Sciences USD 1.9B 57M 2026-09
Incyte USD 134.25M 21.71M 2026-09
Ionis Pharmaceuticals USD 28.58M 22.26M 2026-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Novartis USD 6.1B 116M 2026-09
Pfizer USD 10.02B 77M 2026-09
PTC Therapeutics USD 109.33M 17.98M 2026-09
Puma Biotechnology USD 9.48M 885K 2025-09
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 876.12M 28.15M 2026-09
TG Therapeutics USD 194.32M 46.35M 2026-09
Ultragenyx Pharmaceutical USD 59M 0 2026-09
Vertex Pharmaceuticals USD 2.25B 480.2M 2026-09